CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net earnings	$ 421,792	$ 276,508
Adjustments to reconcile net earnings to net cash provided by operating activities:
Stock-based compensation expense	163,945	150,324
Depreciation	42,427	32,664
Impairments and amortization of intangibles	33,921	251,838
Deferred income taxes	44,789	6,517
Other adjustments, net	6,647	1,362
Changes in assets and liabilities
Accounts receivable	(100,134)	6,985
Other assets	7,457	53,757
Accounts payable and other liabilities	15,701	(467,343)
Income taxes payable and receivable	7,779	(11,721)
Deferred revenue	(23,652)	(440)
Net cash provided by operating activities	620,672	300,451
Cash flows from investing activities:
Cash used in business combinations, net of cash acquired	0	(25,681)
Capital expenditures	(50,020)	(38,373)
Other, net	2,444	2,615
Net cash used in investing activities	(47,576)	(61,439)
Cash flows from financing activities:
Payments to settle exchangeable notes	0	(117,755)
Proceeds from the settlement of exchangeable note hedges	0	61,459
Payments to settle warrants related to exchangeable notes	0	(7,482)
Proceeds from issuance of common stock pursuant to stock-based awards	16,407	16,788
Withholding taxes paid on behalf of employees on net settled stock-based awards	(5,933)	(106,688)
Purchase of treasury stock	(445,108)	(482,049)
Purchase of noncontrolling interests	(1,872)	(10,554)
Other, net	0	10
Net cash used in financing activities	(436,506)	(646,271)
Total cash provided (used)	136,590	(407,259)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(2,104)	(17,501)
Net increase (decrease) in cash, cash equivalents, and restricted cash	134,486	(424,760)
Cash, cash equivalents, and restricted cash at beginning of period	572,516	815,512
Cash, cash equivalents, and restricted cash at end of period	$ 707,002	$ 390,752